32
Participants
Start Date
June 30, 2008
Primary Completion Date
June 30, 2013
Study Completion Date
June 30, 2013
Intradiscal rhGDF-5
The API is recombinant human growth and differentiation factor-5 (rhGDF-5), a recombinant version of human GDF-5. GDF-5 is a member of the transforming growth factor-b (TGF-b) superfamily and the bone morphogenetic protein (BMP) subfamily, and is known to influence the growth and differentiation of various tissues, including the intervertebral disc. In vitro experiments have shown that rhGDF-5 can stimulate gene expression and synthesis of the extracellular matrix proteins type II collagen and aggrecan. In vivo experiments in rabbit models of disc degeneration have shown that intradiscal injections of rhGDF-5 can stimulate an increase in disc height and hydration.
Virginia Commonwealth University Spine Center, Richmond
Drug Studies America, Marietta
Riverhills Healthcare, Inc., Cincinnati
Rehabilitation Institute of Chicago, Chicago
TBI Clinical Research, LLC, Plano
Durango Orthopedic Associates/Spine Colorado, Durango
Spine Institute, Santa Monica
Massachusetts General Hospital, Boston
Lead Sponsor
DePuy Spine
INDUSTRY